Polo-like kinase 1 (Plk1) inhibitor

Negative control for VZ185

Novel, natural auxin efflux inhibitor, promoting lateral root formation

JBP923 analog, exerting potent therapeutic effect on inflammatory bowel disease (IBD)

Potent inhibitor of MRSA PK

Positive modulator of GABA A receptors

Non-Specific Anticoagulant Reversal Agent

Broad-spectrum antimicrobial carboxyfluoroquinoline, interfering with the bacterial DNA gyrase, inhibiting the DNA synthesis, and preventing bacterial cell growth

Novel modulator of SLC6A19, robustly, selectively, and reproducibly inhibiting SLC6A19

Agonist of the 5-HT1 and 5-HT4 receptors and as an antagonist of the 5-HT2 receptors

5-HT2 antagonist

ß-Adrenergic agonist

Noncompetitive inhibitor of Candida albicans growth and activity of (1-3)-beta-glucan synthase

Cell permeable caged inositol triphosphate, promoting Ca2+-release from internal stores under UV photolysis

Altered peptide ligand containing a novel CD4 T-cell epitope of human heat shock protein 60 (83-109)

Novel 3C-like protease inhibitor of SARS-CoV-2

Platelet activation inhibitor

Inhibitor of human tyrosyl-DNA phosphodiesterase 1 (TDP1); Delayed death inhibitor of the malarial parasite plastid; Inhibitor of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-1 (PLIN1); Inhibit

Inhibitor of PLAP and TNAP

Novel specific inhibitor of bacterial AddAB helicase-nuclease DNA repair enzyme

Potent inhibitor of cancer cell growth with microtubule-binding activity

Potent inhibitor of HIV-1 nucleocapsid (NC)-DNA interaction; specifically bound NC with nanomolar affinity, and showed modest anti-HIV-1 activity in ex vivo cell assays

Novel Stimulator of Hepatitis C Virus NS3 Helicase-Catalyzed ATP Hydrolysis

Potent inhibitor of ROCK2 enzymatic activity

Potent inhibitor of cancer cell growth with microtubule-binding activity

Novel Inhibitor of the Major Facilitator Superfamily (MFS) of Efflux Pump Transporters.

Novel lopinavir analogue against COVID-19, forming the most stable complex with the Mpro

Novel inhibitor of Cdc42 that act by blocking nucleotide binding with no effect on RhoA or Rac

Blocker of integrin binding to its endothelial receptor (VCAM-1)

Antibacterial agent, being effective in treating dapsone resistant leprosy